BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 31795034)

  • 1. Rasagiline, a monoamine oxidase B inhibitor, reduces in vivo [
    Ng KP; Therriault J; Kang MS; Struyfs H; Pascoal TA; Mathotaarachchi S; Shin M; Benedet AL; Massarweh G; Soucy JP; Rosa-Neto P; Gauthier S
    Neuroimage Clin; 2019; 24():102091. PubMed ID: 31795034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoamine oxidase B inhibitor, selegiline, reduces
    Ng KP; Pascoal TA; Mathotaarachchi S; Therriault J; Kang MS; Shin M; Guiot MC; Guo Q; Harada R; Comley RA; Massarweh G; Soucy JP; Okamura N; Gauthier S; Rosa-Neto P
    Alzheimers Res Ther; 2017 Mar; 9(1):25. PubMed ID: 28359327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroimaging-pathological correlations of [
    Ishiki A; Harada R; Kai H; Sato N; Totsune T; Tomita N; Watanuki S; Hiraoka K; Ishikawa Y; Funaki Y; Iwata R; Furumoto S; Tashiro M; Sasano H; Kitamoto T; Kudo Y; Yanai K; Furukawa K; Okamura N; Arai H
    Acta Neuropathol Commun; 2018 Jun; 6(1):53. PubMed ID: 29958546
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Ezura M; Kikuchi A; Okamura N; Ishiki A; Hasegawa T; Harada R; Watanuki S; Funaki Y; Hiraoka K; Baba T; Sugeno N; Yoshida S; Kobayashi J; Kobayashi M; Tano O; Ishiyama S; Nakamura T; Nakashima I; Mugikura S; Iwata R; Taki Y; Furukawa K; Arai H; Furumoto S; Tashiro M; Yanai K; Kudo Y; Takeda A; Aoki M
    Front Aging Neurosci; 2021; 13():761010. PubMed ID: 34912209
    [No Abstract]   [Full Text] [Related]  

  • 5.
    Hsu JL; Chen SH; Hsiao IT; Lu CS; Yen TC; Okamura N; Lin KJ; Weng YH
    Sci Rep; 2020 Nov; 10(1):19410. PubMed ID: 33173080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [
    Brendel M; Schönecker S; Höglinger G; Lindner S; Havla J; Blautzik J; Sauerbeck J; Rohrer G; Zach C; Vettermann F; Lang AE; Golbe L; Nübling G; Bartenstein P; Furukawa K; Ishiki A; Bötzel K; Danek A; Okamura N; Levin J; Rominger A
    Front Aging Neurosci; 2017; 9():440. PubMed ID: 29387005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. THK5351 and flortaucipir PET with pathological correlation in a Creutzfeldt-Jakob disease patient: a case report.
    Kim HJ; Cho H; Park S; Jang H; Ryu YH; Choi JY; Moon SH; Oh SJ; Oh M; Na DL; Lyoo CH; Kim EJ; Seeley WW; Kim JS; Choi KC; Seo SW
    BMC Neurol; 2019 Aug; 19(1):211. PubMed ID: 31464590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Added Value of Tau-PET in the Assessment of Progressive Supranuclear Palsy.
    López-Mora DA; Fernández León A; Lleó A; Blesa R; Camacho V
    Clin Nucl Med; 2020 May; 45(5):e239-e240. PubMed ID: 32149810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo measurement of brain monoamine oxidase B occupancy by rasagiline, using (11)C-l-deprenyl and PET.
    Freedman NM; Mishani E; Krausz Y; Weininger J; Lester H; Blaugrund E; Ehrlich D; Chisin R
    J Nucl Med; 2005 Oct; 46(10):1618-24. PubMed ID: 16204711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-in-Humans Evaluation of
    Villemagne VL; Harada R; Doré V; Furumoto S; Mulligan R; Kudo Y; Burnham S; Krishnadas N; Bozinovski S; Huang K; Lopresti BJ; Yanai K; Rowe CC; Okamura N
    J Nucl Med; 2022 Oct; 63(10):1551-1559. PubMed ID: 35086898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Head to head comparison of [
    Jang YK; Lyoo CH; Park S; Oh SJ; Cho H; Oh M; Ryu YH; Choi JY; Rabinovici GD; Kim HJ; Moon SH; Jang H; Lee JS; Jagust WJ; Na DL; Kim JS; Seo SW
    Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):432-442. PubMed ID: 29143870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlations of
    Harada R; Ishiki A; Kai H; Sato N; Furukawa K; Furumoto S; Tago T; Tomita N; Watanuki S; Hiraoka K; Ishikawa Y; Funaki Y; Nakamura T; Yoshikawa T; Iwata R; Tashiro M; Sasano H; Kitamoto T; Yanai K; Arai H; Kudo Y; Okamura N
    J Nucl Med; 2018 Apr; 59(4):671-674. PubMed ID: 28864633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and preclinical characterization of [
    Kroth H; Oden F; Molette J; Schieferstein H; Capotosti F; Mueller A; Berndt M; Schmitt-Willich H; Darmency V; Gabellieri E; Boudou C; Juergens T; Varisco Y; Vokali E; Hickman DT; Tamagnan G; Pfeifer A; Dinkelborg L; Muhs A; Stephens A
    Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2178-2189. PubMed ID: 31264169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tau positron-emission tomography tracer AV-1451 binds with similar affinities to tau fibrils and monoamine oxidases.
    Vermeiren C; Motte P; Viot D; Mairet-Coello G; Courade JP; Citron M; Mercier J; Hannestad J; Gillard M
    Mov Disord; 2018 Feb; 33(2):273-281. PubMed ID: 29278274
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Schonhaut DR; McMillan CT; Spina S; Dickerson BC; Siderowf A; Devous MD; Tsai R; Winer J; Russell DS; Litvan I; Roberson ED; Seeley WW; Grinberg LT; Kramer JH; Miller BL; Pressman P; Nasrallah I; Baker SL; Gomperts SN; Johnson KA; Grossman M; Jagust WJ; Boxer AL; Rabinovici GD
    Ann Neurol; 2017 Oct; 82(4):622-634. PubMed ID: 28980714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of Distribution of 18F-THK5351 Positron Emission Tomography in Alzheimer's Disease Continuum.
    Nihashi T; Sakurai K; Kato T; Iwata K; Kimura Y; Ikenuma H; Yamaoka A; Takeda A; Arahata Y; Washimi Y; Suzuki K; Bundo M; Sakurai T; Okamura N; Yanai K; Ito K; Nakamura A;
    J Alzheimers Dis; 2022; 85(1):223-234. PubMed ID: 34776443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tau imaging with [
    Ishiki A; Harada R; Okamura N; Tomita N; Rowe CC; Villemagne VL; Yanai K; Kudo Y; Arai H; Furumoto S; Tashiro M; Furukawa K
    Eur J Neurol; 2017 Jan; 24(1):130-136. PubMed ID: 27797445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (S)-[
    Alzghool OM; Rokka J; López-Picón FR; Snellman A; Helin JS; Okamura N; Solin O; Rinne JO; Haaparanta-Solin M
    Neuropharmacology; 2021 Sep; 196():108676. PubMed ID: 34216585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-interaction of tau PET tracers with monoamine oxidase B: evidence from in silico modelling and in vivo imaging.
    Murugan NA; Chiotis K; Rodriguez-Vieitez E; Lemoine L; Ågren H; Nordberg A
    Eur J Nucl Med Mol Imaging; 2019 Jun; 46(6):1369-1382. PubMed ID: 30919054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET Imaging of Astrogliosis and Tau Facilitates Diagnosis of Parkinsonian Syndromes.
    Schönecker S; Brendel M; Palleis C; Beyer L; Höglinger GU; Schuh E; Rauchmann BS; Sauerbeck J; Rohrer G; Sonnenfeld S; Furukawa K; Ishiki A; Okamura N; Bartenstein P; Dieterich M; Bötzel K; Danek A; Rominger A; Levin J
    Front Aging Neurosci; 2019; 11():249. PubMed ID: 31572166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.